TNFR1
2 papers1 finding
- Human trial2
Interventions
1Conjugated equine estrogens
downin humans1
1 study
Conjugated equine estrogens
downin humans1
Conjugated equine estrogens decrease TNFR1 in humans (-234 pg/mL, p = .0006).
“-234 pg/mL (p = .0006), and -1374 pg/mL (p < .0001), respectively] than for tE2”
Human trialmenopausal womenoral conjugated equine estrogenserum36 monthsfemalesn = 37
Effect of menopausal hormone therapy on proteins associated with senescence and inflammation
Physiological reports1 Aug 2020
Latest
6 in 12 monthsADA Scientific Sessions 2026 Abstract
Large-Scale Proteomic Discovery of Prognostic and Treatment-Responsive CKD Biomarkers in SELECT
Randomised trial in 11,000 peopleChronic kidney disease
AAIC 2025 Abstract
Synergistic effects of GFAP with TNFR1 and TNFR2 on conversion to AD dementia and overall survival across the Alzheimer's disease spectrum
Cohort study of 190 peopleDementia
GSA 2025 Abstract
Systemic Inflammation and Its Interaction with Alzheimer’s Disease Pathology in Accelerating Cognitive Decline
Study in peopleMechanisms
GSA 2025 Abstract
Caloric Restriction and Changes in Geroscience Blood-Based Biomarkers in Older Adults
Randomised trial in 768 peopleDietary restriction
Physiological Reports
Effect of menopausal hormone therapy on proteins associated with senescence and inflammation
Randomised trial in peopleInterventions
The Journal of Nutrition, Health & Aging
A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans
Cohort study of 883 peopleBiomarkers